《中国高血压临床实践指南》解读——护理实践要点及管理策略

doi:10.16352/j.issn.1001-6325.2025.07.0974

摘要/Abstract

摘要： 2024年9月,最新版《中国高血压临床实践指南》发布,该指南针对当前高血压诊断、评估和治疗领域的若干重要内容,形成了44个关键临床问题和99条推荐意见,强调将降压治疗防线前移,强化降压治疗,体现了加强初始预防和一级预防的理念,强调生活方式干预和血压监测的重要性,对临床工作具有重要指导价值和实践意义。本文将从护理实践角度出发,对高血压患者的管理策略进行解读,以期为临床护理工作提供循证指导。

关键词: 高血压, 临床实践指南, 护理实践, 解读

Abstract: In September 2024, the updated version of Chinese Clinical Practice Guidelines for Hypertension was published. This version of guidelines comprises 44 pivotal clinical inquiries and 99 recommendations pertaining to the diagnosis, assessment, and management of hypertension. The new version of the guidelines emphasizes moving the line of defense of antihypertensive treatment forward, strengthening antihypertensive treatment, reflecting the concept of strengthening initial prevention and primary prevention, and stressing the importance of lifestyle intervention and blood pressure monitoring, which is of great guiding value and practical significance to clinical work. This paper interprets the management strategy of hypertension patients from the perspective of nursing practice,in order to provide evidence-based guidance for clinical nursing work.

Key words: hypertension, clinical practice guidelines, nursing practice, interpretation

中图分类号:

R544.1

李英霞, 李文明, 余秋华, 吴楠. 《中国高血压临床实践指南》解读——护理实践要点及管理策略[J]. 基础医学与临床, 2025, 45(7): 974-980.

LI Yingxia, LI Wenming, YU Qiuhua, WU Nan. Interpretation on the Chinese Clinical Practice Guidelines for Hypertension: Key points of nursing practice and management strategies[J]. Basic & Clinical Medicine, 2025, 45(7): 974-980.

参考文献

[1] NCD Risk Factor Collaboration (NCD-RisC).Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019:a pooled analysis of 1201 population-representative studies with 104 million participants[J]. Lancet,2021,398:957-980.
[2] The Writing Committee of the Annual Report on Cardiovascular Health and Diseases in China.Interpretation of the annual report on cardiovascular health and diseases in China 2022[J]. Cardiol Discov,2024,4:5880.
[3] 中华医学会心血管病学分会,海峡两岸医药卫生交流协会高血压专业委员会,中国康复医学会心血管疾病预防与康复专业委员会.中国高血压临床实践指南[J]. 中华心血管病杂志,2024,52:985-1032.
[4] 娄莹,蔡军.防线前移时不我待:中国高血压积极防控的时代已来[J]. 协和医学杂志,2024,15:1238-1241.
[5] Chen H,Cui Z,Lu W,et al.Geographical,sex,age,and seasonal differences in serum manganese status among Chinese adults with hypertension[J]. Biol Trace Elem Res,2023,201:41-50.
[6] Dumitrascu-Biris D, Nzelu D, Dassios T,et al.Chronic hypertension in pregnancy stratified by first-trimester blood pressure control and adverse perinatal outcomes:a prospective observational study[J]. Acta Obstet Gynecol Scand,2021,100:1297-1304.
[7] 马丽媛,王增武,樊静,等.《中国心血管健康与疾病报告 2021》关于中国高血压流行和防治现状[J]. 中国全科医学,2022,25:3715-3720.
[8] 陈磊,张鑫,叶润宇,等.高血压靶器官损害评估新进展[J]. 中华高血压杂志,2021,29:1002-1009.
[9] Kadomatsu Y, Tsukamoto M, Sasakabe T,et al.A risk score predicting new incidence of hypertension in Japan[J]. J Hum Hypertens,2019,33:748-755.
[10] McEvoy JW, McCarthy CP, Bruno RM,et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension[J]. Eur Heart J,2024,45:3912-4018.
[11] Mancia G, Kreutz R, Brunström M,et al.2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension:Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)[J]. J Hypertens,2023,41:1874-2071.
[12] 娄莹,马文君,王子君,等.中国高血压临床实践指南计划书[J]. 中华心血管病杂志,2022,50:671-675.
[13] Balshem H, Helfand M, Schünemann HJ,et al. GRADE guidelines: 3. Rating the quality of evidence[J]. J Clin Epidemiol,2011,64:401-406.
[14] The State Council.State council measures to enhance people′s fitness,health[EB/OL]. (2019-07-15)[2024-09-20]. http://english.www.gov.cn/policies/latestreleases/20190715/contentWS5d2c6f8fc6d05cbd94d67a02.html.
[15] 中华医学会心血管病学分会,中国康复医学会心脏预防与康复专业委员会,中国老年学和老年医学会心脏专业委员会,等.中国心血管病一级预防指南[J]. 中华心血管病杂志,2020,48:1000-1038.
[16] Li J,Zhao D,Cai J,et al.Cost-effectiveness of treatment inadults with blood pressure of 130-139/80-89 mmHg andhigh cardiovascular risk in China:a modelling study[J]. Lancet Reg Health West Pac,2023:100962.doi:10.1016/j.lanwpc.2023.100962.
[17] 张丽娟,刘敏,李志娟,等.诊室血压波动的影响因素及不同测量方法对血压分级的影响[J]. 郑州大学学报(医学版),2022,57:400-405.
[18] 中国老年医学学会高血压分会,国家老年疾病临床医学研究中心中国老年心血管病防治联盟.中国老年高血压管理指南2019[J]. 中华老年病研究电子杂志, 2019, 6:1-27.
[19] Viera AJ,Yano Y,Lin FC,et al. Does this adult patient have hypertension?:the rational clinical examination systematic review[J]. JAMA,2021,326:339-347.
[20] 蒋弼瀛,黄佳宇,陈文佳.肿瘤相关高血压的血压管理的研究进展[J]. 心血管病学进展,2024,45:52-56.
[21] Juhanoja EP, Puukka PJ, Johansson JK,et al.The impact of the day of the week on home blood pressure:the Finn-Home study[J]. Blood Press Monit,2016,21:63-68.
[22] Fu J,Liu Y,Zhang L,et al.Nonpharmacologic Interven-tions for reducing blood pressure in adults with prehypertension to established hypertension[J]. J Am Heart Assoc,2020,9:e016804. doi: 10.1161/JAHA.120.016804.
[23] Krishnamoorthy Y, Nagarajan R, Murali S.Effectiveness of multiple combined lifestyle interventions in reducing blood pressure among patients with prehypertension and hypertension:a network Meta-analysis[J]. J Public Health (Oxf),2023,45:e319-e331.
[24] 国家卫生健康委员会.中国居民营养与慢性病状况报告(2020年)[J]. 营养学报,2020,42:521.
[25] Hanssen H, Boardman H, Deiseroth A,et al.Personalizedexercise prescription in the prevention and treatment ofarterial hypertension:a consensus document from theEuropean Association of Preventive Cardiology (EAPC)and the ESC Council on Hypertension[J]. Eur J Prev Cardiol,2022,29:205-215.
[26] Wu Y, Johnson BT, Chen S, et al. Tai Ji Quan as antihypertensive lifestyle therapy: a systematic review and Meta-analysis[J]. J Sport Health Sci,2021,10:211-221.
[27] Zhang P, Zhang D, Lu D. The efficacy of Tai Chi for essential hypertension: a systematic review and Meta-analysis[J]. Int J Nurs Pract,2024,30:e13211. doi: 10.1111/ijn.13211.
[28] Ma J, Ma L, Lu S, et al. The effect of traditional Chinese exercises on blood pressure in patients with hypertension: a systematic review and Meta-analysis[J]. Evid Based Complement Alternat Med,2023,2023:2897664.doi:10.1155/202312897664.
[29] Zhu Z, Yan W, Yu Q, et al. Association between exercise and blood pressure in hypertensive residents: a Meta-analysis[J]. Evid Based Complement Alternat Med, 2022,2022:2453805.
[30] Global BMI Mortality Collaboration, Di Angelantonio E, Bhupathiraju ShN, et al.Body-mass index and all-cause mortality:individual-participant-data meta-analysis of 239 prospective studies in four continents[J]. Lancet,2016,388:776-786.
[31] 中华医学会内分泌学分会肥胖学组.中国成人肥胖症防治专家共识[J]. 中华内分泌代谢杂志,2011,27:711-717.
[32] 王增武.《中国高血压防治指南(2024年修订版)》更新要点解读[J]. 中国心血管杂志,2024,29:391-395.
[33] Mackenzie IS, Rogers A, Poulter NR, et al. Cardiovas-cular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial[J]. Lancet, 2022, 400: 1417-1425.

编辑推荐 0

Metrics

阅读次数

全文

HTML			PDF

最新录用	在线预览	正式出版	最新录用	在线预览	正式出版
0	0	0	0	0	9

	来源	本网站

	次数	9
	比例	100%

摘要

最新录用	在线预览	正式出版

0	0	56

	来源	本网站

	次数	56
	比例	100%